StockDriftsStockDriftsTop 4 Qiming U.s. Ventures Management, Llc Holdings
| Stock | Company | % Port. | Shares | Value | Activity | Ownership | Avg. Cost | Date |
|---|---|---|---|---|---|---|---|---|
| TRML | TOURMALINE BIO INC | 63.76% | 741.7K | $35.5M | +0.00%(+0) | $20.33(+136.03%) | 2025-09-30 | |
| KRRO | KORRO BIO INC | 31.68% | 368.1K | $17.6M | +0.00%(+0) | $44.21(-81.64%) | 2025-09-30 | |
| JSPR | JASPER THERAPEUTICS INC | 3.97% | 929.0K | $2.2M | +0.00%(+0) | $93.19(-98.11%) | 2025-09-30 | |
| KZR | KEZAR LIFE SCIENCES INC | 0.58% | 82.9K | $323K | +0.00%(+0) | $122.38(-94.82%) | 2025-09-30 |
| Performance Metric | 3-Year Annualized | 3-Year Cumulative | 5-Year Annualized | 5-Year Cumulative | Since First Filing (12 quarters) |
|---|---|---|---|---|---|
| Top 20 Holdings Weighted | +5.57% | +17.65% | — | — | +17.65% |
| Top 20 Holdings Unweighted | +39.03% | +168.72% | — | — | +168.72% |
Qiming U.s. Ventures Management, Llc reports $55.64M in US-listed equity holdings across 4 positions in its most recent 13F filing. Its largest disclosed positions are TRML (63.8%), KRRO (31.7%) and JSPR (4.0%). The top 20 holdings account for 99.99% of reported assets. Its disclosed equity book has returned +17.65% on a three-year cumulative basis. Figures reflect the Q3 2025 filing.
Sign up free to track Qiming U.s. Ventures Management, Llc, compare funds side by side, and get alerts the moment positions change.
Holdings on this page are parsed from Qiming U.s. Ventures Management, Llc’s Form 13F filings with the U.S. Securities and Exchange Commission (CIK 1909617). View Qiming U.s. Ventures Management, Llc’s 13F filings on SEC